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Abstract
One prevalent theory of learning states that dopamine neurons signal mismatches between 
expected and actual outcomes, called temporal difference errors (TDEs). Evidence indicates that 
dopamine system dysfunction plays a role in negative symptoms of schizophrenia (SZ), including 
avolition and anhedonia. As such, we predicted that brain responses to TDEs in dopamine 
midbrain nuclei and target areas would be abnormal in SZ. Eighteen clinically-stable patients with 
chronic schizophrenia and 18 controls participated in an fMRI study, which used a passive 
conditioning task. In the task, the delivery of a small amount of juice followed a light stimulus by 
exactly 6 seconds on approximately 75% of 78 total trials, and was further delayed by 4–7 s on the 
remaining trials. The delayed juice delivery was designed to elicit the two types of TDE signals, 
associated with the recognition that a reward was omitted at the expected time, and delivered at an 
unexpected time. Main effects of TDE valence and group differences in the positive – negative 
TDE contrast (unexpected juice deliveries – juice omissions) were assessed through whole-brain 
and regions-of-interest (ROI) analyses. Main effects of TDE valence were observed for the entire 
sample in the midbrain, left putamen, left cerebellum, and primary gustatory cortex, bilaterally. 
Whole-brain analyses revealed group differences in the positive – negative TDE contrast in the 
right putamen and left precentral gyrus, while ROI analyses revealed additional group differences 
in the midbrain, insula and parietal operculum, on the right, the putamen and cerebellum, on the 
left, and the frontal operculum, bilaterally. Further, these group differences were generally driven 
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by attenuated responses in patients to positive TDEs (unexpected juice deliveries), whereas 
responses to negative TDEs (unexpected juice omissions) were largely intact. Patients also showed 
reductions in responses to juice deliveries on standard trials, and more blunted reinforcer 
responses in the left putamen corresponded to higher ratings of avolition. These results provide 
evidence that SZ patients show abnormal brain responses associated with the processing of a 
primary reinforcer, which may be a source of motivational deficits.
Keywords
schizophrenia; dopamine; reinforcement; basal ganglia; temporal difference error
Introduction
In addition to positive, or psychotic symptoms, schizophrenia (SZ) is characterized by 
negative symptoms, reflecting deficits in areas such as motivation, emotional expression, 
and speech production. These negative symptoms have been shown to relate closely to 
functional impairments exhibited by patients (Green et al 2000; Tamminga et al 1998), 
particularly with regards to engagement in goal-directed behavior. The fact that patients also 
show deficits on experimental tasks of reinforcement learning suggests that dysfunctional 
reinforcement processing mechanisms may contribute to negative symptoms. This idea is 
further supported by evidence that brain dopamine (DA) systems, which are known to play a 
pivotal role in modulating reinforcement learning (Montague et al 2004), are disrupted in 
schizophrenia (Abi-Dargham et al 2000; Breier et al 1997; Laruelle et al 1996; Okubo et al 
1997). As such, the purpose of our study was to investigate whether disrupted reward 
processing mechanisms contribute to deficits in motivated behavior in schizophrenia by 
examining the role of DA in reward processing.
One prevalent theory of DA system function is that DA cells signal, through phasic 
modulations of their firing rates, the registration of mismatches between reinforcer 
expectations and outcomes (Schultz et al 1997), known as “reward prediction errors,” or 
“temporal difference errors” (TDEs; if they pertain to the timing of reinforcement). 
Neuroimaging studies with human subjects have observed activation changes in both 
(presumably) dopaminergic midbrain nuclei (Aron et al 2004) and dopamine target 
structures (Berns et al 2001; McClure et al 2003; Seymour et al 2004) in association with the 
perception of prediction errors. McClure and colleagues (2003) found that an area of the left 
putamen showed significantly decreased activation, relative to baseline, when a juice 
reinforcer was omitted at the expected time (corresponding to a negative TDE). This area 
also showed increased activation when the reinforcer was unexpectedly delivered 10 
seconds after the light cue (corresponding to a positive TDE).
The results of several studies (Jensen et al 2008; Murray et al 2007), in fact, suggest that SZ 
patients have specific impairment in the perception and representation of prediction errors. 
Murray et al. (2007) found differential activations between psychotic patients and controls in 
the dopaminergic midbrain in response to unexpected monetary outcomes in an operant 
learning paradigm. In learning to choose between stimuli predicting monetary outcomes, 
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patients showed attenuated neural responses to outcomes that were better or worse than 
expected, whereas their responses to neutral outcomes were somewhat elevated, relative to 
those of controls. Corlett et al. (2007) found that prediction-error evoked fMRI activity in 
prefrontal cortex (PFC) was strongly predictive of clinical ratings of delusional thought 
content, as measured by the Brief Psychiatric Rating Scale (BPRS; Overall and Gorman 
1962).
Study objectives and predictions
Multiple studies (Corlett et al 2007; Murray et al 2007) have identified abnormalities in 
prediction signaling in the context of higher-level cognitive tasks using a symbolic 
reinforcer (e.g., money). Determining whether or not there are alterations in responses 
prediction errors regarding a primary reinforcer (e.g., a food reinforcer) can make an 
important contribution to the interpretation of the above findings, by helping to establish 
whether these findings generalize to more elementary forms of learning. In order to address 
this issue, we implemented a version of the Pavlovian classical conditioning paradigm 
employed by McClure and colleagues (2003), which used a juice reinforcer, in conjunction 
with fMRI. This paradigm enabled us to separately investigate neural responses to positive 
and negative prediction errors in SZ patients. Furthermore, our study was specifically 
designed to examine the signaling of errors in predictions about the timing of a reinforcer 
(TDEs) in schizophrenia. Finally, because we hypothesized that faulty TDE processing is at 
the root of deficits in reward-driven learning and behavior, our goal was to investigate 
relationships between reinforcer responses and ratings of negative symptoms.
Based on evidence of both disrupted DA function in SZ (Abi-Dargham et al 2000; Breier et 
al 1997; Laruelle et al 1996; Okubo et al 1997) and deficits in reinforcement learning driven 
by both positive and negative feedback (Prentice et al in press; Waltz et al 2007; Waltz and 
Gold 2007), we hypothesized that patients would show abnormal brain correlates of both 
positive and negative TDEs. Based on our formulation that negative symptoms in SZ reflect 
a reduced ability of rewards and punishments to modulate learning and motivate behavior in 
SZ patients, we further hypothesized that patients would show systematic relationships 
between ratings of negative symptoms, such as avolition, and brain responses to the 
presence and absence of rewards.
Participants and Methods
Recruiting and Screening of Participants
Eighteen patients and 18 demographically-matched healthy controls participated in the study 
(Table 1). All participants provided written informed consent to a protocol approved by the 
institutional review boards at the National Institute on Drug Abuse and the University of 
Maryland School of Medicine. All participants were right-handed, as determined by the 
Edinburgh Handedness Inventory (Oldfield 1971).
All patients were on stable antipsychotic medication regimens (no changes for four weeks), 
almost all with second-generation antipsychotic drugs (Supplementary Table 1). The 
diagnosis of schizophrenia or schizoaffective disorder in patients was confirmed using the 
SCID-I (First et al 1997), as was the absence of Axis I diagnoses in control participants. 
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Control participants diagnosed with Axis II personality disorders (based on screening with 
the SIDP-R; Pfohl et al 1989) were also excluded. Participants in both experimental groups 
underwent medical screening, involving a medical history and physical exam, and subjects 
with evidence of any neurological or medical condition that might confound data 
interpretation were excluded (such as significant head injury, stroke or severe vascular 
problems, chronic untreated diabetes, etc.). Further exclusionary criteria included: 
pregnancy, current illegal drug use (both verified by urine screens), and admission of past 
substance dependence.
Procedures
Events prior to MRI scanning—Participants were instructed to abstain from alcohol for 
24 hours prior to each visit, which was verified by a breathalyzer test prior to each session. 
Subjects were fluid-deprived for 3 hours prior to the actual MRI session to increase the 
value of the juice, which served as a primary reinforcer (see below).
Experimental task (TDE paradigm)—Participants underwent a classical conditioning 
task (Berns et al 2001; McClure et al 2003; see Figure 1). Prior to actual MRI scanning, 
participants were trained in a mock scanner to associate the receipt of a juice reward with 
the presentation of a light stimulus (a large yellow disc on a black background, which was 
displayed on a screen behind the subject’s head and viewed through a mirror attached to the 
head coil). During training, participants completed three runs of 26 ‘standard’ trials each, 
during which the light-juice interval was always 6 seconds. Following training, subjects 
performed the same task in the MRI scanner. During scanning, however, a number of ‘catch’ 
events were introduced. On catch trials the juice was not delivered at the ‘expected’ time 
point, but rather 4–7 seconds after the expected delivery. Based on McClure et al. (2003), 
we predicted that this type of catch event would induce a negative prediction error at the 
time when juice was not delivered as expected, and that a subsequent positive prediction 
error would be incurred by the ‘unexpected’ delivery of juice. The number of paired training 
events outnumbered the catch events by a ratio of approximately 3:1 in scanning sessions. 
The time between individual trials ranged from 4–12 seconds.
Prior to training, participants chose one type of commercially available juice from three 
options: apple, grape, or fruit punch. Juice was delivered through small-bore IV tubing 
connected to syringes set into an MR-compatible syringe pump (Harvard Apparatus; Boston, 
Massachusetts). The end of the tubing was placed in the participant’s mouth, attached to a 
commercial sports mouth-guard to stabilize the tube. A 600-μl squirt of juice was delivered 
on each trial, at a rate of 1 ml/second (duration=0.6 s). Between runs of the TDE task, 
subjects rated the pleasantness of the juice stimuli, by moving a cursor on a visual-analog 
scale using a wheel manipulandum, with a rating of 8 representing extreme liking, and rating 
of 0 representing extreme aversion.
Interval Timing Test—The capacity of an individual to learn the association between the 
light cue and the juice reward is reliant upon their ability to accurately estimate the time at 
which they should (based on previous learning) expect receipt of the reward. To assess time 
estimation abilities, participants completed a short test of timing function, based on the work 
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of Rao and colleagues (Harrington et al 2004; Hinton et al 2004), outside of the MRI 
scanner and following all other experimental phases. On each trial, subjects were presented 
with three temporal intervals, defined by four beeps, and asked to judge whether the third 
interval was shorter than, longer than, or the same as the two preceding intervals. The first 
two intervals were 6 s in all cases, while the third ranged from 4.5 to 7.5 s, in increments of 
0.5 s. Thus, the timing paradigm assessed the ability to estimate a similar time interval as 
was used in the TDE/classical conditioning paradigm, albeit demanding much greater 
precision.
Other Psychological Assessments—Cognitive function was assessed in all 
participants using three standard measures: the Wechsler Abbreviated Scale of Intelligence 
(WASI; Wechsler 1999), the Wechsler Test of Adult Reading (WTAR; Wechsler 2001), and 
the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS; 
Randolph et al 1998; Wilk et al 2005). In order to quantify the ability of study participants to 
experience pleasure both physically and in social contexts, we had all subjects complete the 
Scales for Physical and Social Anhedonia (Chapman et al 1976). Standard symptom ratings 
were obtained for all patients using the BPRS (Overall and Gorman 1962), the Scale for the 
Assessment of Negative Symptoms (SANS; Andreasen 1984), and the Calgary Depression 
Scale (CDS; Addington et al 1992).
Acquisition and Analysis of fMRI Data
MRI scanning—A 3-T Siemens Allegra scanner (Erlangen, Germany) acquired whole-
brain functional EPI images for measurement of T2*-weighted BOLD effects (4-mm 
oblique axial slices, 30° axial to coronal; 64 × 64 matrix; FOV = 22 × 22 cm; TR = 2 s; TE = 
27 ms; FA = 80°). In each scanning session, a whole-brain oblique axial T1-weighted 
structural image (MPRAGE) was acquired for anatomical reference (1-mm3 isotropic 
voxels; TR = 2.5 s; TE = 4.38 ms; FA = 80°).
Whole-brain analyses of MRI data—All preprocessing and first-level analyses of MRI 
data were performed using the AFNI software package (Analysis of Functional 
NeuroImages; Cox 1996). Preprocessing steps included volume-registration for motion 
correction, slice-timing correction, and temporal normalization. In order to generate 
statistical parametric maps for individual subjects, we used an approach similar to McClure 
et al. (2003) and D’Ardenne et al. (2008). We used three types of events as regressors in 
regression analyses: juice deliveries on standard trials, and positive and negative TDEs 
(juice deliveries and omissions on catch trials, respectively). Regressors were modeled by an 
idealized hemodynamic response function and its temporal derivative, time-locked to the 
event onsets. Additional regressors of no-interest included the six motion-correction curves.
For the purposes of this study, we examined responses only after learning because it 
provides the strongest method for studying TDE responses in isolation, while avoiding 
dependencies on exact learning-model parameters. That is, when learning is complete, 
positive and negative prediction errors evoked by changing the time of reward can be fully 
modeled without dependence on how effective TDEs were in driving learning.
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Beta weights from the first-level analysis were spatially normalized to Talairach space and 
smoothed with a 4.2 mm FWHM Gaussian kernel prior to second-level (i.e. group) analyses. 
The main second-level analyses were two separate repeated-measures ANOVAs, performed 
to determine brain areas showing significant main effects of group, event type, and group x 
event type interactions: one with factors of group (patients vs. control) and TDE valence 
(positive vs. negative), and one with factors of group and trial-type (catch vs. standard, to 
compare responses to ‘unexpected’ and ‘expected’ deliveries of the reinforcer). Correction 
for multiple comparisons was accomplished using a Monte Carlo simulation, which 
determined a minimum cluster size required for a given voxel-wise threshold. This 
simulation determined that, for our chosen voxel-wise threshold (p<0.002), a minimum 
cluster size of 11 voxels (424 μl) was required to achieve an overall significance level of p < 
0.05.
Analyses of group differences in regions of interest (ROI)—In order to compare 
the performance of the two groups in regions involved in the processing of the reinforcer, as 
well as prediction errors, we selected all significant clusters showing significant main effects 
of TDE valence and all clusters showing significant group X TDE valence interactions. This 
criterion yielded 11 ROIs, described below. Based on the results of McClure et al. (2003), 
which used the same paradigm to examine prediction-error-related brain activity in healthy 
volunteers, we selected two additional regions of interest a priori, in the left and right 
putamen by drawing spheres of 5 mm radius around their Talairach coordinates (±18, 2, 8). 
Thus, we performed further analyses on 13 total ROIs. Reported p-values based on this 
group analysis for a priori regions of interest were corrected for the number of comparisons 
made within each region.
Correlation analyses—We used Spearman correlation analyses to assess relationships 
among timing task performance, clinical ratings of avolition (to assess reductions in goal-
directed behavior in schizophrenia), and BOLD responses to juice deliveries in the 11 ROIs 
identified functionally, and the 2 ROIs identified a priori. Clinical ratings of avolition were 
determined by summing the four items from the avolition subscale of the 25-item SANS.
Results
Brain regions distinguishing positive from negative TDEs
A two-way ANOVA with factors of group and TDE valence was performed to determine the 
brain regions distinguishing positive from negative TDEs in the entire sample (N=36; see 
Table 2a). This ANOVA produced five brain regions showing main effects of TDE valence, 
all of which resulted from activations to positive TDEs and deactivations to negative TDEs. 
Regions showing main effects of TDE valence included left putamen and the right midbrain, 
consistent with previous findings (D’Ardenne et al 2008; McClure et al 2003; Murray et al 
2007; see Figure 2a–c). Large areas also emerged, centered on the left and right frontal and 
parietal operculum, extending into insular cortex. These areas correspond to primary 
gustatory cortex, as identified in previous studies (Lee et al 1998; Small et al 1999). For the 
purpose of ROI analysis, we divided each of the large areas into three components, based on 
their overlap with precentral gyrus, postcentral gyrus, and insula, as identified by the 
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Talairach daemon (Lancaster et al 2000). Together with an additional cluster emerging in 
the declive of the cerebellum, this yielded 9 ROIs for further analysis. Note that a main 
effect of group, without respect to TDE valence, is difficult to interpret, because we 
expected (and observed) activations for positive TDEs, and deactivations for negative TDEs; 
thus, we do not report this effect.
Two brain regions, the right putamen and in the left frontal operculum, showed significant 
group × TDE valence interactions (Table 2b, Figure 2d–f). In these two areas, controls 
showed BOLD activations to positive TDEs and deactivations to negative TDEs, whereas 
patients showed the opposite (aberrant) pattern (see Figure 3b–c, ROIs 10 and 11).
ROI analyses of group differences in the positive – negative TDE contrast
With 11 regions emerging from whole-brain analyses, and 2 regions chosen a priori, we 
performed additional analyses on 13 total ROIs. In 9 of the 13 ROIs investigated, the two 
subject groups differed in the magnitude of the [positive – negative] TDE contrast (the 
difference trended toward significance in ROI 13, the right putamen; Figure 3a). This was 
true despite the fact that in nine of these regions (ROIs 1–9), the magnitude of the [positive 
– negative] TDE contrast was significantly different from zero within the patient group (all 
t’s > 2.75; see Figure 3a).
Further analyses revealed that group differences in the [positive – negative] TDE contrast 
were generally driven by attenuated responses to positive TDEs in the patient group (all t’s > 
3.10; Figure 3b). Whereas controls showed significant activations to positive TDEs, relative 
to baseline, in all 13 ROIs, patients showed significant activations to positive TDEs only in 
the pre- and postcentral gyrus, bilaterally (ROIs 5–8). In response to negative TDEs, 
however, patients and controls did not differ significantly in their responses to negative 
TDEs in any of the ROIs (Figure 3c), with patients showing robust deactivations, relative to 
baseline, in nine regions (ROIs 1–9), including the midbrain and left putamen.
Together, these analyses indicate that group differences in BOLD signal modulations, due to 
the valence of prediction errors, generally result from attenuated responses in patients to 
unexpected administrations of the reinforcer. In order to determine whether patients’ 
responses to positive TDEs were selectively disrupted, or if patients showed more general 
dysfunction in neural processing of the reinforcer, we performed analyses comparing 
subjects’ responses to unexpected (catch) versus expected (standard) juice deliveries.
MRI responses to non-TDE events
Juice deliveries on standard vs. catch trials—A two-way ANOVA of group X trial-
type was performed to compare unexpected deliveries of reward (positive TDEs) with 
expected reward delivery (null TDEs). This analysis revealed significant main effects of 
group in numerous areas, regardless of whether they occurred on standard or catch trials 
(Table 3). Controls showed more positive responses to juice delivery than patients, 
regardless of trial type, in all of these areas, which overlapped with many of the ROIs 
identified above, including midbrain, left and right putamen, left and right frontal 
operculum, and left insular cortex.
Waltz et al. Page 7
Neuropsychopharmacology. Author manuscript; available in PMC 2013 August 15.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Also in our previously identified ROIs, participants within each group showed similar 
responses to juice deliveries on standard and catch trials, with controls showing significant 
activations to both in all regions (relative to baseline; compare Figures 3b and 3d). In three 
of the 13 ROIs, in fact, BOLD responses to expected juice deliveries and unexpected juice 
deliveries correlated significantly in the patient group (see Supplementary Table 2).
No region showed a significant main effect of trial-type, and no brain region showed a 
significant group X trial-type interaction. Thus, we did not find evidence of an enhanced 
neural response to (presumably unexpected) juice deliveries on catch trials, relative to juice 
deliveries on standard trials.
MRI responses to the light cue—It should be noted that patients did not show 
attenuated activations, or deactivations to all event types; brain responses to the reward-
predicting cue (the conditioned stimulus) were largely intact in SZ patients (see 
Supplementary Table 3; Supplementary Figure 1).
Behavioral and Correlation Analyses
Timing Task Performance—Patients and controls differed significantly in their 
performance on the interval timing task done outside the scanner [t(31)=3.38; p=0.002]. 
Whereas patients correctly estimated only 45.8% (SD=12.1%) of test intervals, controls 
correctly estimated 61.6% (SD=14.7%) of test intervals.
When we computed Spearman correlation coefficients for relationships between scores on 
the interval timing task and MRI responses to standard juice deliveries, we observed a single 
significant correlation: timing task performance in patients related systematically to 
responses to standard juice deliveries in the left frontal operculum/precentral gyrus (Table 
4).
Anhedonia and Avolition—Exploratory analyses of relationships between BOLD data 
and rating of clinical symptoms revealed that avolition subscores from the SANS correlated 
negatively with MRI responses to standard juice deliveries in the left frontal and parietal 
operculum (pre- and postcentral gyrus; Table 4). Furthermore significant negative 
correlations were observed between avolition ratings and MRI responses to standard juice 
deliveries in the left and right a priori putamen ROIs, and six additional ROIs showed 
correlations of medium effect size (d > 0.3; Cohen 1992). In all of these ROIs, patients with 
the highest ratings of avolition showed the least positive BOLD responses to juice 
deliveries. Supplementary Figure 2 illustrates this pattern in the left frontal operculum and 
the left putamen ROIs.
By contrast, avolition ratings bore no relationship to self-reports of reinforcer enjoyment 
(Spearman’s rho = −0.023), which did not differ between patients and controls [mean rating 
of 5.8 (1.4) for patients vs. mean of 5.3 (1.1) for controls; t(34)=1.25; p>0.10]. Avolition 
ratings also bore no relationship to self-reports of physical (ρ = −0.287) and social 
anhedonia (ρ = −0.037) from the Chapman scales. Patients and controls also did not differ 
significantly on these measures [t(34)<1.6; p>0.10 in both cases; see Table 1].
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Discussion
In this functional MRI study of prediction error-related activity, our data led us to draw the 
following conclusions: 1. Multiple components of reward circuits showed responses that 
distinguished between positive and negative TDEs in the entire sample of participants; 2. 
Patients with schizophrenia showed reduced contrasts in brain activity evoked by positive 
and negative TDEs in multiple brain areas, driven largely by attenuated responses to positive 
TDEs; 3. Patients showed attenuated responses in numerous brain regions to delivery of the 
juice reinforcer on standard trials, as well; and 4. Clinical ratings of avolition correlated 
significantly with brain activity evoked by standard juice delivery in the primary gustatory 
cortex and putamen. Each of these findings will be addressed in turn.
Contrasts between positive and negative TDEs
When combined across groups, neural activity distinguished between positive and negative 
temporal difference errors in multiple brain regions. Consistent with the results of McClure 
and colleagues (D’Ardenne et al 2008; McClure et al 2003), these areas included the 
midbrain and the left putamen. Both ventral and dorsal areas of the neostriatum have been 
identified as components of circuits for reward-based learning (Haber et al 2006; Voorn et al 
2004), and a role for these areas in outcome processing, in particular, is supported by the 
results of several previous neuroimaging studies (Delgado et al 2005; Delgado et al 2000; 
McClure et al 2003). Our results provide further evidence that projections from the midbrain 
to the basal ganglia comprise a critical component of circuits for processing outcomes, and 
mismatches between expectations and outcomes.
Additionally, significant contrasts between unexpected juice delivery and omissions were 
observed, bilaterally, in the insula and the frontal and parietal operculum, consistent with the 
results of previous studies that have linked these areas to gustation (Lee et al 1998), general 
interoception (Craig 2003; Critchley et al 2004), and the processing of outcomes (Paulus et 
al 2005; Seymour et al 2004).
Group differences in responses to TDEs
Whole-brain analyses revealed that patients showed a reduced BOLD contrast between 
positive and negative TDEs in right putamen and the left frontal operculum. Additional ROI 
analyses revealed group differences in the [positive – negative] TDE contrast in the right 
midbrain, the left putamen, right primary gustatory cortex, and left cerebellum.
Evidence of abnormal prediction-error responses in schizophrenia suggests a possible factor 
underlying reinforcement learning deficits commonly observed in patients (Kemali et al 
1987; Keri 2008; Schwartz et al 2003). Our finding of attenuated prediction-error-related 
activity in schizophrenia is consistent with the results of a recent neuroimaging study 
(Murray et al 2007), which found evidence of abnormal prediction error responses in the 
midbrain, among other brain regions, in SZ patients performing an operant learning 
paradigm. Several other studies have identified attenuated responses in the striatum in SZ 
patients (Kumari et al 2002; Reiss et al 2006), associated with the feedback-driven learning 
of procedures.
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We observed group differences between patients and controls mainly for positive prediction 
errors (unexpected juice delivery), rather than negative prediction errors (unexpected juice 
omissions). This finding suggests that sensitivity to outcomes that are worse than expected 
(negative TDEs) might be relatively preserved in schizophrenia. The relatively intact 
response to negative TDEs in patients in the present study was somewhat unexpected, in 
light of the behavioral evidence pointing to impaired online error-correction behavior in 
schizophrenia (Prentice et al in press; Waltz and Gold 2007).
It is possible, however, that the type of the learning involved, specifically in terms of 
whether subjects need to explicitly represent feedback and use it to make rapid adjustments 
in behavior, may influence the extent to which brain signals associated with negative 
prediction errors are abnormal in schizophrenia. Despite relatively clear evidence of deficits 
in the ability to use feedback to make rapid adjustments in behavior, other behavioral results 
indicate that punishment-driven learning may be unimpaired in SZ patients if the learning 
task is of a probabilistic or procedural nature (Waltz et al 2007). The fact that the passive 
conditioning task in the current study has been shown to depend largely on striatal regions, 
implicated in procedural learning, might explain our finding of largely intact neural 
responses to negative TDEs in patients. It is possible, furthermore, that the negative TDE 
error signal is intact in schizophrenia, but that the ability of target brain areas to use error 
information to modulate response selection and learning is disrupted.
Responses to reinforcer deliveries on standard trials
Contrary to our expectations, patients also showed attenuated responses in numerous brain 
regions to delivery of the juice reinforcer on standard trials. Furthermore, we observed that 
neuronal activity evoked by juice delivery in the left primary gustatory cortex and bilateral 
putamen correlated significantly with clinical ratings of avolition. These findings, together 
with our observation that BOLD responses to expected and unexpected juice deliveries 
correlated significantly in three ROIs in the patient group, suggest that abnormal processing 
of the juice reinforcer was a contributing factor to the attenuated positive prediction error 
signals in SZ patients, and that reductions in goal-directed behavior frequently observed in 
schizophrenia patients may be influenced by abnormal processing of rewards.
Findings regarding the experience of rewards in schizophrenia are mixed. Evidence from 
behavioral studies (Cohen and Minor 2008; Gard et al 2007; Germans and Kring 2000) 
supports, in large part, the idea that patients with schizophrenia have intact self-reported 
experience of rewards. Indeed, patients in the present study reported finding the juice just as 
pleasant as controls did. These findings, however, appear to be contradicted by the results of 
multiple neuroimaging studies (Crespo-Facorro et al 2001; Paradiso et al 2003; Plailly et al 
2006), which have found evidence of abnormal neural responses to pleasant stimuli in 
schizophrenia (especially primary reinforcers, such as pleasant odors). Furthermore, 
multiple studies have found evidence of reduced gray matter volume in components of 
reward processing circuitry, such as insula and ventral prefrontal cortex (Crespo-Facorro et 
al 2000; Davatzikos et al 2005).
One possible explanation for this apparent dichotomy is that, even if patients report normal 
hedonic experiences, the physiology underlying those hedonic experiences might still be 
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abnormal. Several previous studies have found differential brain responses between SZ 
patients and controls, despite similar behavioral performance on learning tasks (Murray et al 
2007; Zedkova et al 2006), as well as similar reports of emotional experience (Takahashi et 
al 2004). A disconnect between the reported experience of rewards, and the associated 
physiology, may partly explain the reduced ability of rewards and punishments to motivate 
behavior in schizophrenia. In short, patients who do not report a reduced experienced of 
pleasure might function like those who do, if the physiology underlying the experience of 
pleasure is abnormal. This view is supported by our finding that ratings of avolition in 
patients correlate most strongly with neural responses to the juice reinforcer, whereas 
avolition ratings bore no relationship to self-reports of reinforcer enjoyment.
It is possible that the strong response to juice delivery on standard trials, in components of 
reward circuits in controls, stemmed from the frequency of “catch” trials in our paradigm 
(roughly ¼ of total trials). A much lower proportion of nonstandard events has been used in 
some paradigms where infrequency was used to enhance the salience of an event (see, e.g., 
Zink et al 2006; Zink et al 2004). In our study, expectations may have changed across the 
course of the session, causing MRI responses to the reinforcer on standard and catch trials to 
become more similar.
Our observation of a significant correlation between timing task performance in patients, 
and neural responses to standard juice delivery in the left frontal operculum, suggests that it 
is also possible that group differences in interval timing abilities contributed to group 
differences in brain responses to TDEs. However, the fact that SZ patients showed largely 
intact responses to omissions of the reinforcer (negative TDEs) contradicts this, suggesting 
that patients had developed a relatively normal expectation as to the timing of standard juice 
deliveries. Thus, poor interval estimation is likely to make only a minor contribution to 
attenuated physiological responses to prediction errors in SZ patients.
Might the altered neurophysiological response to juice rewards reflect the impact of 
antipsychotic medications that attenuate dopamine signaling rather than an effect that can be 
considered to be a consequence of the illness? Previous studies have not produced a clear 
picture of what the impact of antipsychotic medications on reward processing might be. At 
least two studies using pharmacological challenge in normal volunteers have found that 
antipsychotic drugs modulate feedback-related brain activity (Abler et al 2007; Zirnheld et 
al 2004). On the other hand, results from studies of reward processing in patients with 
schizophrenia are mixed. Juckel and colleagues (2006a; 2006b) found that unmedicated SZ 
patients and patients on first-generation (typical) antipsychotics showed attenuated activity 
in ventral striatum, relative to controls. However, treatment with olanzapine appears to 
produce a relative normalization of reward anticipation BOLD response in the ventral 
striatum (relative to activity observed in patients treated with typical antipsychotics; Juckel 
et al 2006a; Schlagenhauf et al 2008). Thus, at least in the case of a symbolic reinforcer, 
some antipsychotic medications may actually enhance brain activity related to reward 
anticipation in SZ patients.
The design of the present study does not allow us to address this question in a 
straightforward fashion. In the absence of random assignment to drug type and dose, any 
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post-hoc analysis of medication effects is confounded. That is, it is not possible to evaluate 
drug dose and type independently of the illness features and treatment history that led to the 
choice of that drug and dose. This may be a particular concern in the patient group studied 
here, where 1/3 of individuals were receiving clozapine – evidence of treatment resistance. 
Thus, in principle, our findings of abnormal reward processing physiology may be limited to 
treated patients. In order to answer the critical question of whether these abnormalities are 
intrinsic to the illness would require a very ambitious study design where patients are 
evaluated off medication and then again on medication, with the need to randomly assign 
drug type and dose in order to comprehensively address this issue.
The fact that our findings may only generalize to treated patients does not diminish the 
clinical importance of the results, because the great majority of patients with schizophrenia 
take antipsychotic medications. Such patients demonstrate altered reward processing, and 
the correlations between brain reward signal modulation and negative symptoms suggest 
that this physiological response is related to core features of the illness – features that are 
highly treatment resistant and are highly predictive of functional disability.
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Figure 1. 
Classical Conditioning Task. Timing of events on normal and “catch” trials. On catch 
events, delivery of the juice reward occurs 10–13 second after the light cue, instead of the 
usual 6 seconds. During the training session (outside of the MRI scanner), subjects were 
presented only with the standard light-juice interval (6 s). During the MRI scanning session, 
catch trials were interspersed among the standard trials, representing approximately 1/4 of 
total trials.
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Figure 2. 
Regions emerging from whole-brain analyses. a–c. Regions showing differential responses 
to positive and negative TDEs within the entire sample (N=36). Midbrain contrasts are 
shown in panels a and b, while contrasts in putamen and insula are depicted in panels b and 
c. d–f. Areas showing group X TDE valence interactions. Panel d shows right putamen, 
while panels e and f show region in left precentral gyrus. In all coronal and transverse slices, 
radiological convention is used, depicting the left hemisphere on the right side of the image.
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Figure 3. 
a. Contrast in MRI activity evoked by positive and negative TDEs in each group, in each 
ROI. b. Analysis of MRI activity evoked by positive TDEs, relative to baseline. c. Analysis 
of MRI activity evoked by negative TDEs, relative to baseline. d. Analysis of MRI activity 
evoked by standard juice deliveries, relative to baseline. In all panels, * indicates group 
difference significant at p < 0.05. MRI signal changes expressed in arbitrary units (A.U.).
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